A narrative review found obesity independently worsens psoriasis severity and blunts response to fixed-dose biologics, ...
Setmelanotide produced a mean body mass index (BMI) reduction of 16.5% in patients with acquired hypothalamic obesity, compared with a 3.3% increase among those receiving placebo, according to trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results